Breakthrough daily diabetes tablet to treat all British heart failure sufferers secures NHS approval
All British heart failure sufferers (file photo) will now be eligible for a breakthrough daily tablet, dapagliflozin, that dramatically reduces symptoms and boosts survival chances.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cardiology | Dapagliflozin | Diabetes | Endocrinology | Forxiga | Health | Heart | Heart Failure | UK Health